Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 23547647)

1.

The impact of the type of insurance plan on adherence and persistence with antidepressants: a matched cohort study.

Assayag J, Forget A, Kettani FZ, Beauchesne MF, Moisan J, Blais L.

Can J Psychiatry. 2013 Apr;58(4):233-9.

PMID:
23547647
2.

Comparison of the adherence and persistence to inhaled corticosteroids among adult patients with public and private drug insurance plans.

Cyr MC, Beauchense MF, Lemiere C, Blais L.

J Popul Ther Clin Pharmacol. 2013;20(1):e26-41. Epub 2013 Jan 30.

3.

Impact of drug plans on adherence to and the cost of antihypertensive medications among patients covered by a universal drug insurance program.

Després F, Perreault S, Lalonde L, Forget A, Kettani FZ, Blais L.

Can J Cardiol. 2014 May;30(5):560-7. doi: 10.1016/j.cjca.2013.11.032. Epub 2013 Dec 10.

PMID:
24613090
4.

Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.

Tournier M, Moride Y, Crott R, du Fort GG, Ducruet T.

J Affect Disord. 2009 May;115(1-2):160-6. doi: 10.1016/j.jad.2008.07.004. Epub 2008 Aug 9.

PMID:
18694602
5.

Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.

Moisan J, Grégoire JP.

Clin Ther. 2010;32 Suppl 1:S21-31. doi: 10.1016/j.clinthera.2010.01.003.

PMID:
20152549
6.

Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data.

Lachaine J, Petrella RJ, Merikle E, Ali F.

Can J Cardiol. 2008 Apr;24(4):269-73.

7.

Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data.

Lachaine J, Rinfret S, Merikle EP, Tarride JE.

Am Heart J. 2006 Jul;152(1):164-9.

PMID:
16824851
8.

New measure of adherence adjusted for prescription patterns: the case of adults with asthma treated with inhaled corticosteroid monotherapy.

Blais L, Kettani FZ, Beauchesne MF, Lemière C, Perreault S, Forget A.

Ann Pharmacother. 2011 Mar;45(3):335-41. doi: 10.1345/aph.1P719. Epub 2011 Mar 8.

PMID:
21386018
9.

Use and reimbursement costs of smoking cessation medication under the Quebec public drug insurance plan.

Tremblay M, Payette Y, Montreuil A.

Can J Public Health. 2009 Nov-Dec;100(6):417-20.

PMID:
20209733
10.

Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting.

Dragomir A, Côté R, White M, Lalonde L, Blais L, Bérard A, Perreault S.

Value Health. 2010 Jan-Feb;13(1):87-94. doi: 10.1111/j.1524-4733.2009.00583.x. Epub 2009 Aug 20.

PMID:
19695008
11.

Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.

Bollinger ME, Diette GB, Chang CL, Stephenson JJ, Sajjan SG, Fan T, Allen-Ramey FC.

Clin Ther. 2010 Jun;32(6):1093-102. doi: 10.1016/j.clinthera.2010.06.003.

PMID:
20637964
12.

The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder.

Wu CH, Erickson SR, Piette JD, Balkrishnan R.

Res Social Adm Pharm. 2012 May-Jun;8(3):193-205. doi: 10.1016/j.sapharm.2011.04.002. Epub 2011 Sep 28.

PMID:
21955808
13.
14.

Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma.

Marceau C, Lemière C, Berbiche D, Perreault S, Blais L.

J Allergy Clin Immunol. 2006 Sep;118(3):574-81.

PMID:
16950273
15.

Impact of better adherence to statin agents in the primary prevention of coronary artery disease.

Perreault S, Dragomir A, Blais L, Bérard A, Lalonde L, White M, Pilon D.

Eur J Clin Pharmacol. 2009 Oct;65(10):1013-24. doi: 10.1007/s00228-009-0673-0. Epub 2009 Jun 16.

PMID:
19529927
16.

The risks and costs of multiple-generic substitution of topiramate.

Duh MS, Paradis PE, Latrémouille-Viau D, Greenberg PE, Lee SP, Durkin MB, Wan GJ, Rupnow MF, LeLorier J.

Neurology. 2009 Jun 16;72(24):2122-9. doi: 10.1212/WNL.0b013e3181aa5300.

PMID:
19528520
17.

Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan.

Hwang DK, Liu CJ, Pu CY, Chou YJ, Chou P.

JAMA Ophthalmol. 2014 Dec;132(12):1446-52. doi: 10.1001/jamaophthalmol.2014.3333.

PMID:
25211300
18.

The relationship of antidepressant prescribing concentration to treatment duration and cost.

Hodgkin D, Merrick EL, Hiatt D.

J Ment Health Policy Econ. 2012 Mar;15(1):3-11.

19.
20.

Persistence with treatment in newly treated middle-aged patients with essential hypertension.

Perreault S, Lamarre D, Blais L, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J.

Ann Pharmacother. 2005 Sep;39(9):1401-8. Epub 2005 Aug 2.

PMID:
16076920
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk